News

Care Hospitals, one of India’s leading healthcare providers, today announced the launch of its new state-of-the-art 24x7 ...
Efficacy and Safety Outcomes over 12 weeks with OCS-01 Eye Drops in DME From DIAMOND-Stage 1 trial: Focus on Subgroup by Prior Treatment Status -- Presenter: Veeral Sheth, M.D., MBA, FACS, FASRS ...
Glenmark Pharma to launch eribulin mesylate injection, 1mg/2 mL (0.5 mg/mL) single-dose vials: Our Bureau, Mumbai Tuesday, September 2, 2025, 17:45 Hrs [IST] Glenmark has announce ...
NIHR awards £6.5 million to establish a UK-wide Commercial Research Delivery Centre Network: United Kingdom Tuesday, September 2, 2025, 17:00 Hrs [IST] The National Institute for ...
Krupanidhi Career Expo puts talent, tech, and accountability at the heart of pharma’s future: Our Bureau, Bengaluru Tuesday, September 2, 2025, 17:20 Hrs [IST] Krupanidhi Colleg ...
Novartis Leqvio shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain: Basel Tuesday, September 2, 2025, 14:00 Hrs [IST] Nov ...
UTSA & UT Health San Antonio complete merger to become The University of Texas at San Antonio: San Antonio, Texas Tuesday, September 2, 2025, 15:00 Hrs [IST] UTSA and The Universi ...
FIP sets out policy statement for responsible use of artificial intelligence in pharmacy practice: Our Bureau, Bengaluru Tuesday, September 2, 2025, 15:30 Hrs [IST] The Internatio ...
AstraZeneca announces BaxHTN phase III trial of baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control ...
Clarivate to organise 16th annual Pharmavision India conference on Sept 3 at Taj Krishna in H’bad: Our Bureau, Bengaluru Tuesday, September 2, 2025, 12:00 Hrs [IST] Clarivate Pl ...
Zydus Lifesciences launches trivalent influenza vaccine, VaxiFlu in India: Our Bureau, Mumbai Tuesday, September 2, 2025, 13:30 Hrs [IST] Zydus Lifesciences Ltd., a global innovat ...